A US-based CBD company has urged for better European regulation.
Mile High Labs, which describes itself as the world’s largest processor of hemp-derived cannabidiol (CBD), has recently visited the European Parliament to ask for clearer regulation and uniformity of the regulatory process across all member states. Currently, while the EU has adopted a classification of CBD as a ‘novel food’, implementation of that novel food characterisation is left up to each member state.
Speaking at an event organised by Laurene Tran, of Active, the European CBD trade association, Wendi Young, VP of Regulatory and Compliance for Mile High Labs, said that the growth in CBD sales and the huge potential of the market going forward necessitates a clearer and more robust regulatory framework.
“All the data we have shows a huge increase in sales of CBD across the EU, and projections for even more intense growth going forward. That can and must be matched
by a regulatory framework which is not only robust and clear enough to protect consumers, but also which is imposed across all the member states,” she commented “We welcome the EU’s classification of CBD as a ‘novel food’ and we are working proactively in the UK and at European level to embrace that process. However, consumers
need to be better protected through regulatory oversight to ensure that products are manufactured in accordance with appropriate good manufacturing practices.”
